The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No ClinVar Id was directly found from the curated document
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001354304.2:c.749C>T

CA386295701

Gene: PAH (HGNC:5053)
Condition: phenylketonuria (MONDO:0009861)
Inheritance Mode: Autosomal recessive inheritance
UUID: 918f78dd-ba44-4fd9-9dd6-6417e8d6b430
Approved on: 2026-04-15
Published on: 2026-04-15

HGVS expressions

NM_001354304.2:c.749C>T
NC_000012.12:g.102852908G>A
CM000674.2:g.102852908G>A
NC_000012.11:g.103246686G>A
CM000674.1:g.103246686G>A
NC_000012.10:g.101770816G>A
NG_008690.1:g.69695C>T
NG_008690.2:g.110503C>T
ENST00000553106.6:c.749C>T
ENST00000307000.7:c.734C>T
ENST00000549247.6:n.508C>T
ENST00000553106.5:c.749C>T
NM_000277.1:c.749C>T
NM_000277.2:c.749C>T
NM_001354304.1:c.749C>T
NM_000277.3:c.749C>T
More

Likely Pathogenic

Met criteria codes 4
PP3_Moderate PP4 PM1 PM2_Supporting
Not Met criteria codes 2
PM3 PS3

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Phenylketonuria Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for PAH Version 2.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
The c.749C>T variant in PAH is a missense variant predicted to cause substitution of serine by phenylalanine at amino acid 250 (p.Ser250Phe). At least one patient with this variant displayed plasma phenylalanine concentration persistently above 120umol/L (2mg/dL), which is highly specific for PAH deficiency (PMID: 28982351). This individual was compound heterozygous for the variant and a variant of uncertain significance confirmed in trans by parental testing (0.25 PM3 points, PM3 does not apply). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). This variant resides within a region, amino acids 246-266, of PAH that is defined as a critical functional domain by the ClinGen PAH Variant Curation Expert Panel (PM1). The computational predictor REVEL gives a score of 0.938, which is above the threshold of 0.644, evidence that correlates with deleterious impact to PAH function; as PM1 is applied PP3 will be applied at the moderate level as not to exceed strong (PP3_moderate). In summary, this variant meets the criteria to be classified as Likely pathogenic for autosomal recessive PAH deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen PAH Variant Curation Expert Panel: PM1, PP3_moderate, PP4, PM2_supporting (PAH VCEP specifications version 2.0.0; approved July 16, 2024).
Met criteria codes
PP3_Moderate
REVEL 0.938
PP4
Detected in a patient with PAH deficiency (373 μmol/L Phe). Patients with BH4 cofactor deficiency were excluded by BH4 loading. PMID: 28982351
PM1
Missense substitution of residues important in cofactor binding of PAH: Ser250
PM2_Supporting
Absent from gnomAD v4
Not Met criteria codes
PM3
Detected in trans by parental testing with a missense variant of unknown significance p.Arg53His (PMID: 28982351) 0.25 points
PS3
the levels of mutant PAH proteins decreased significantly compared to the wild type control, in both E. coli and HEK293T cells. The lower expression in mutant groups indicated that PAH protein expression was impaired by variants. Exact numbers or % of wt were not reported.

Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.